Study guide
7.3 Order of Draw and Tube Additives
AMT Certified Medical Laboratory Assistant CMLA
Track your progress as you read
Finished sections get a check mark.
1 Introduction
1.1 Current Exam Facts 1.2 Blueprint Weights and Study Strategy
2 Chapter 2: Safety Terminology and Infection Control
2.1 Safety, Infection, and OSHA Terminology 2.2 Chain of Infection and Precautions 2.3 Isolation, Aseptic Technique, and Disease Prevention
3 Chapter 3: OSHA, HazCom, and Public-Health Reporting
3.1 OSHA Bloodborne Pathogens and Needlestick Safety 3.2 Hazard Communication, SDS, and GHS 3.3 Mandated Safety Rules and Public-Health Reporting
4 Chapter 4: Quality Assessment and Quality Control
4.1 Quality Control and Assessment Terminology 4.2 QC vs QA, Internal vs External QC, and Proficiency Testing 4.3 Daily QC, Temperature Logs, and Corrective Action 4.4 Instrument Maintenance and Calibration in CMLA Scope
5 Chapter 5: Waived-Test Integrity and Confirmatory Testing
5.1 Off-Label Waived Testing and High-Complexity Default 5.2 Following Manufacturer Instructions for Waived Tests 5.3 Confirmatory and Supplemental Testing
6 Chapter 6: Phlebotomy Foundations
6.1 Phlebotomy Terminology and Equipment 6.2 Serum, Plasma, Whole Blood, and Anticoagulation 6.3 Patient Identification and Container Identification
7 Chapter 7: Venipuncture, Order of Draw, and Specimen Integrity
7.1 Patient Preparation and Physiologic Effects 7.2 Vein Selection and Venipuncture Technique 7.3 Order of Draw and Tube Additives 7.4 Short Draws, Hemolysis, and Plasma-on-Cells Limits
8 Chapter 8: Capillary Collection, Processing, and Legal Specimens
8.1 Capillary Puncture Including Infants 8.2 Post-Care, Labeling, Transport, Processing, and Send-Outs 8.3 Specimens Used as Legal Evidence
9 Chapter 9: Non-Blood Collection and Preanalytical Errors
9.1 Urine Collection Types and Patient Instruction 9.2 Urine Suitability, Storage, Preservatives, and Rejection 9.3 Other Specimens and Time/Temperature Requirements 9.4 Shipping, Slide Prep, Preanalytical Errors, and Complications
10 Chapter 10: Clinical Chemistry
10.1 Clinical Chemistry Terminology and Test Families 10.2 Chemistry Instrumentation, Cleaning, and Maintenance 10.3 Point-of-Care and Waived Chemistry Testing 10.4 Toxicology Within CMLA Scope
11 Chapter 11: Hematology and Coagulation
11.1 Hematology Terminology, Blood Functions, and Cell Types 11.2 Hematology Instrumentation, QC, and Calibration 11.3 Coagulation: PT, PTT, INR, Heparin, and Warfarin 11.4 Point-of-Care and Waived Hematology Tests
12 Chapter 12: Immunology, Serology, and Immunohematology
12.1 Antigen-Antibody Principles 12.2 Blood Types, Rh, and Immunohematology Basics 12.3 Waived Immunology, Serology, and Immunohematology Procedures
13 Chapter 13: Microbiology
13.1 Microbiology Terminology and Specimen Appropriateness 13.2 Aseptic Processing, Storage, and Transport of Micro Specimens 13.3 Media, Cultures, and Procedure Matching 13.4 Stains, KOH, Wet Preps, Reagents, and Controls
14 Chapter 14: Urinalysis and Microscopy
14.1 Urinalysis Terminology 14.2 Waived Urinalysis Procedures and Specimen Handling 14.3 Microscopy Parts, Magnification, Wet Prep, and Cleaning
15 Chapter 15: Basic Anatomy and Physiology
15.1 Anatomy Relevant to Laboratory Testing 15.2 Physiology Relevant to Laboratory Testing
16 Chapter 16: Legal, Ethical, and HIPAA Foundations
16.1 Consent, ABN, Test Ordering, and PPM Restrictions 16.2 Patient's Bill of Rights, Refusal, and Medicolegal Risk 16.3 Professional Appearance, Conduct, and Social Media 16.4 HIPAA Confidentiality and Record Release
17 Chapter 17: Clerical Skills, Communication, and Critical Values
17.1 Reports, Abnormal Results, and Critical-Value Notification 17.2 HIT Data, Inventory, Expirations, and Billing/Coding 17.3 Patient Instruction, Communication, Telephone, and Time Management
7.3 Order of Draw and Tube Additives
Key Takeaways Explain This Topic AI
CLSI-published order of draw is blood culture, sodium citrate (light blue), serum tubes (red/gold/speckled), heparin (green), EDTA (lavender/pearl/pink), then sodium fluoride/potassium oxalate (gray).
SPS/sterile culture containers come first; citrate requires a 9:1 blood-to-anticoagulant fill; clot activator and gel produce serum; heparin inhibits thrombin; EDTA (K2 or K3) chelates calcium; fluoride/oxalate inhibits glycolysis.
EDTA carryover falsely lowers calcium and can raise potassium; EDTA into a citrate tube invalidates PT/aPTT; gel can contaminate trace-metal collections.
A short-draw light-blue citrate tube invalidates coagulation tests because the 9:1 ratio is lost.
Mix by gentle inversion using typical manufacturer IFU counts (citrate about 3–4; EDTA and heparin about 8–10), not a secret AMT number; shaking hemolyzes cells.
Last updated: August 2026
CMLA II.3.B.8.a requires observing proper order of draw . Chapter 6 explained what serum, plasma, EDTA, citrate, heparin, and fluoride/oxalate are. This section is the sequence that keeps one tube's additive from ruining the next. The current venous-collection standard is CLSI PRE02 , 8th edition (2025). Facility color charts that contradict PRE02 without a documented reason are not the exam answer.
Quick Answer: Blood culture → light-blue citrate → serum (red/gold/speckled) → heparin green → EDTA lavender/pearl/pink → gray fluoride/oxalate. Order exists to stop carryover. Light-blue short draw invalidates coagulation (9:1). Invert by typical IFU counts; do not shake.
Why order exists
The same needle carries a film of additive from one tube into the next. Order of draw sequences tubes so the most damaging carryover is least likely. It applies to evacuated-tube holders, butterflies, and syringe-plus-transfer-device fills. Drawing only two tubes does not make order optional if those two are citrate and EDTA in the wrong sequence—or EDTA before a calcium/potassium chemistry tube.
CLSI-published order (PRE02 / CLSI insights):
- Blood culture tube or bottle
- Sodium citrate (light blue)
- Serum tubes, including clot activator and gels (red, gold, speckled)
- Heparin with or without gel (green)
- EDTA with or without gel (lavender, pearl, pink)
- Sodium fluoride/potassium oxalate glycolytic inhibitor (gray)
Unlisted tubes —acid-citrate-dextrose, thrombin, royal-blue trace-element, black sedimentation-rate—are placed by additive-carryover risk , not by leftover supply in the basket. A royal-blue clot tube travels with serum tubes; a royal-blue EDTA tube travels with EDTA. Gel next to a trace-metal tube is a contamination risk.
Additive function by position
Order Typical closure Additive and job CMLA integrity point
1 Culture bottle or yellow SPS tube Sodium polyanethol sulfonate (SPS) and sterile broth; SPS is an anticoagulant that also inhibits complement so organisms can grow Sterility first: never fill a culture after EDTA or other additive tubes
2 Light blue Sodium citrate binds calcium at a calibrated 9:1 blood-to-anticoagulant ratio for PT, aPTT, INR Underfill over-anticoagulates and invalidates coagulation
3 Red, gold, red-speckled Clot activator (silica) ± separator gel for serum chemistry and serology Gel is not an anticoagulant; the tube must still clot
4 Green, light green Heparin (lithium or sodium) inhibits thrombin for plasma chemistry; gel = plasma separator tube Heparin carryover prolongs coagulation tests
5 Lavender, pearl, pink EDTA ( K2 spray-dried or K3 liquid) chelates calcium; lavender CBC, pink blood bank, pearl gel plasma-preparation tube EDTA carryover drops calcium and can raise potassium
6 Gray Sodium fluoride (glycolytic inhibitor / preservative) plus potassium oxalate (anticoagulant) Fluoride preserves glucose; oxalate is the anticoagulant
K2 EDTA is spray-dried on the tube wall in many current products; K3 EDTA is often liquid and slightly dilutes the specimen. Both chelate calcium. Neither is a coagulation tube.
Carryover traps
EDTA into a chemistry tube. Chelation falsely lowers calcium (and can affect magnesium). K-EDTA falsely raises potassium . That is why EDTA is after heparin and serum, not before them.
EDTA into citrate. Extra chelator and wrong additive make PT/aPTT uninterpretable. Citrate must be collected before EDTA.
Heparin into citrate. Thrombin is inhibited in the coagulation specimen, so times prolong.
Clot activator or serum into citrate. Activator can trigger clotting and ruin coagulation.
Gel into trace metals. Separator gel and some stopper materials contaminate trace-element assays. Place unlisted royal-blue tubes by their own additive, away from gel carryover.
Nonsterile additive into a culture. SPS/sterile containers are first so the needle is not wet with EDTA, heparin, or gel when it enters the bottle.
Light-blue short draw
A short-draw light-blue tube does not contain nine parts blood to one part citrate. Excess citrate binds the calcium the assay adds back, so clotting times prolong artifactually. The specimen is invalid —not a little off. Do not add blood from another tube, do not pour EDTA into it, and do not top off with saline. Recollect a full tube. Butterfly tubing that is not cleared with a discard tube when citrate is first is a classic underfill.
Short draws in other additives are Section 7.4. CMLA highlights citrate here because the ratio is the test.
Mixing: typical IFU, not a secret AMT number
Anticoagulant and clot activator sit in the tube before blood arrives. Invert —gentle complete turns—immediately after fill. Do not shake (hemolysis, Section 7.4).
Typical manufacturer instructions for use (IFU) teach about 3–4 inversions for citrate, about 5 for clot-activator serum tubes, and about 8–10 for heparin, EDTA, and fluoride/oxalate. Blood-culture bottles follow the bottle IFU (often a similar 8–10 range). Those counts are typical IFU teaching , not a hidden AMT exam number. If the tube label differs, the IFU wins .
In practice
The order is blood cultures, CBC, basic metabolic panel (serum or heparin plasma per directory), PT, and glucose in fluoride. You draw: culture bottles, light-blue citrate filled to the line, gold or green chemistry tube, lavender EDTA, gray. You invert each additive tube the IFU count as it comes off the needle. You do not draw the lavender first because the nurse said the CBC was the priority, and you do not pour leftover EDTA into the blue top when it underfills.
Exam traps
Reciting an old mnemonic that puts serum last or EDTA first.
Thinking order is optional on a syringe or butterfly.
EDTA before calcium/potassium chemistry or before citrate.
Treating a short-draw light blue as valid if you mix extra hard.
Calling inversion counts a secret AMT number instead of typical IFU.
Assuming gel is an anticoagulant or that SPS is just another EDTA.
When a stem names two stopper colors, answer with carryover chemistry—calcium, potassium, PT—not with which tube was closer in the tray.